{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:57:18Z","timestamp":1781323038028,"version":"3.54.1"},"reference-count":21,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2026]]},"DOI":"10.70352\/scrj.cr.26-0163","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:09:49Z","timestamp":1780956589000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["A Case of Colon Cancer-Induced Hemophagocytic Lymphohistiocytosis with Lymphangitic Carcinomatosis"],"prefix":"10.70352","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4899-4409","authenticated-orcid":false,"given":"Ayaka","family":"Tachikawa","sequence":"first","affiliation":[{"name":"Department of Colorectal Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5881-0036","authenticated-orcid":false,"given":"Kazushige","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Dejima","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Nakamori","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Takao","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Zhou Y-H, Han X-R, Xia F-Q, et al. Clinical features and prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: a retrospective analysis of 227 cases. J Pediatr Hematol Oncol 2022; 44: e217\u201322.","DOI":"10.1097\/MPH.0000000000002283"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) La Ros\u00e9e P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 2019; 133: 2465\u201377.","DOI":"10.1182\/blood.2018894618"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Schram AM, Comstock P, Campo M, et al. Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years. Br J Haematol 2016; 172: 412\u20139.","DOI":"10.1111\/bjh.13837"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ramos-Casals M, Brito-Zer\u00f3n P, L\u00f3pez-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet 2014; 383: 1503\u201316.","DOI":"10.1016\/S0140-6736(13)61048-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Parikh SA, Kapoor P, Letendre L, et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc 2014; 89: 484\u201392.","DOI":"10.1016\/j.mayocp.2013.12.012"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bezerra AS, D\u2019Ippolito G, Faintuch S, et al. Determination of splenomegaly by CT: is there a place for a single measurement? AJR Am J Roentgenol 2005; 184: 1510\u20133.","DOI":"10.2214\/ajr.184.5.01841510"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Henter JI, Horne A, Aric\u00f3 M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124\u201331.","DOI":"10.1002\/pbc.21039"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lee JC, Logan AC. Diagnosis and management of adult malignancy-associated hemophagocytic lymphohistiocytosis. Cancers (Basel) 2023; 15: 1839.","DOI":"10.3390\/cancers15061839"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Nie J, Zhou L, Tian W, et al. Deep insight into cytokine storm: from pathogenesis to treatment. Signal Transduct Target Ther 2025; 10: 112.","DOI":"10.1038\/s41392-025-02178-y"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Abdelhay A, Mahmoud A, Mostafa M, et al. Delay in treatment of adult hemophagocytic lymphohistiocytosis is associated with worse in-hospital outcomes. Ann Hematol 2023; 102: 2989\u201396.","DOI":"10.1007\/s00277-023-05271-w"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Jiao P, Wang S, Wu J, et al. Tislelizumab-induced hemophagocytic lymphohistiocytosis in a patient with microsatellite instability-high colon cancer and coexisting systemic lupus erythematosus: a case report and literature review. Front Oncol 2025; 15: 1585133.","DOI":"10.3389\/fonc.2025.1585133"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Jaffrelot M, Gadaud N, Delord J-P, et al. A case of hemophagocytic lymphohistiocytosis induced by regorafenib. Arch Clin Med Case Rep 2021; 5: 96\u2013100.","DOI":"10.26502\/acmcr.96550332"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Blazevic I, Fares N, Delaunay B, et al. Regorafenib-triggered hemophagocytic lymphohistiocytosis: a report of two cases. Cureus 2024; 16: e72721.","DOI":"10.7759\/cureus.72721"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Lentz RW, Lang J, Pitts TM, et al. Phase II clinical trial and preclinical evaluation of a novel CD47 blockade combination in refractory microsatellite-stable metastatic colorectal cancer. Cancer Res Commun 2025; 5: 2039\u201352.","DOI":"10.1158\/2767-9764.CRC-25-0332"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Yamada T, Ikeya T, Ogawa T, et al. A hemophagocytic syndrome-like condition after emergency colectomy for perforated colon cancer: report of a case. Surg Today 2002; 32: 278\u201381.","DOI":"10.1007\/s005950200036"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Oliveira C, Chacim S, Ferreira I, et al. Secondary hemophagocytic syndrome: the importance of clinical suspicion. Case Rep Hematol 2014; 2014: 958425.","DOI":"10.1155\/2014\/958425"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ali M, Debbarma B. Colonic adenocarcinoma presenting as hemophagocytic syndrome: a case report. J Med Sci Clin Res 2017; 5: 17550\u20135.","DOI":"10.18535\/jmscr\/v5i2.56"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Jim\u00e9nez Rosales R, Mart\u00edn-Rodr\u00edguez MDM, Redondo-Cerezo E. Hemophagocytic syndrome, a diagnostic challenge in gastroenterology. Rev Esp Enferm Dig 2019; 111: 816.","DOI":"10.17235\/reed.2019.6200\/2019"},{"key":"19","unstructured":"19) Lehmberg K, Nichols KE, Henter J-I, et al. Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. Haematologica 2015; 100: 997\u20131004."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Facchini BA, Switzer B, Ernstoff MS, et al. Hemophagocytic lymphohistiocytosis induced by immune checkpoint inhibitors: observations and proposed clinical management. Front Immunol 2026; 16: 1678966.","DOI":"10.3389\/fimmu.2025.1678966"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Zoref-Lorenz A, Allen CE, Behrens EM, et al. Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study. Blood Adv 2026; 10: 1564\u201375.","DOI":"10.1182\/bloodadvances.2024013690"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0163\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:37:43Z","timestamp":1781321863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0163\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.26-0163","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cr.26-0163"}}